Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.13M 1.96M 1.82M 3.46M 232M 3.51M 23.52M 9.15M 114M 9.15M 8.95M 395M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.91M 10.05M 9.33M 17.71M 1.19B 17.95M 120M 46.82M 583M 46.78M 45.76M 2.02B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-2.44%0.00% - - 22.82B
+4.31%+8.36%-27.25%+21.81% 15.69B
-1.76%+7.35%-48.37%-60.16% 8.02B
+1.07%0.00%+9.15%+72.04% 7.57B
+1.20%+18.10%-16.07%+254.92% 4.63B
0.00%+9.13%-40.14%-35.66% 2.22B
-1.17%+1.81%-39.06%-48.47% 1.77B
-0.04%+10.70%+9.81%+44.65% 1.7B
-0.80%+0.57%+3.69%+83.23% 1.54B
Average +0.05%+3.89%-18.53%+41.55% 6.6B
Weighted average by Cap. +0.11%+2.78%-22.17%+37.67%

Financials

2018 2019 *
Net sales 3.32M 2.91M 2.68M 2.49M 4.72M 317M 4.79M 32.08M 12.48M 156M 12.47M 12.2M 539M -
Net income -15.94M -13.96M -12.86M -11.93M -22.66M -1.52B -22.97M -154M -59.9M -746M -59.86M -58.54M -2.59B -
Net Debt 10.02M 8.78M 8.08M 7.5M 14.25M 956M 14.44M 96.77M 37.66M 469M 37.64M 36.81M 1.63B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock